RAD21 and squamous cell carcinoma: After excluding 4 cases with Rad21 mutations and patients with a lack of follow‐up data or without valid data, 236 patients with squamous cell carcinoma entered the overall survive (OS) analysis, and 207 patients for disease‐free survive (DFS).